Global COVID-19 Vaccines Pipeline 2020: 150 Organizations’ Vaccines for COVID-19, SARS and MERS – PRNewswire

DUBLIN, May 14, 2020 /PRNewswire/ -- The "Global Coronavirus Vaccines Pipeline 2020" report has been added to ResearchAndMarkets.com's offering.

COVID-19 vaccine development is proceeding at an unprecedented pace, achieving a substantially accelerated timeframe in comparison to the typical vaccine development process. Part of this rapid pace can be attributed to the prior work done with SARS and MERS and now is being used for COVID-19. The Global Coronavirus Vaccines Pipeline report features a comprehensive data analysis of over 150 organizations working on developing vaccines focused on the ongoing COVID-19 pandemic and the previous SARS and MERS outbreaks.

It provides market intelligence and pipeline analysis on the current available vaccines region-wise, specifically from the Americas, Europe, the Middle East and Africa (EMEA), and the Asia-Pacific region (APAC). It captures detailed profiles of these companies, the ongoing partnerships as well as growth and financial performance analysis. In addition, it pulls together insights from interviews and surveys with key opinion leaders who committed to developing an affordable vaccine for emergency pandemic use. The Global Coronavirus Vaccines Pipeline report seeks to holistically inform the community on the current status of coronavirus vaccine development and discover future opportunities for collaboration, technology transfer and co-development.

In addition, it gives readers access to company profiles, ongoing clinical trials and an assessment of the regulatory environment. Moreover, the report pulls together insights on funding and a swot analysis on the industry. Popular market sentiments derived through comprehensive primary research with key industry stakeholders have been compiled as well.

Key Topics Covered:

Section 1

Section 2: Covid-19 Pipeline Analysis

Section 3: SARS Pipeline Analysis

Section 4: MERS Pipeline Analysis

Section 5: Data Analysis & Intelligence Mapping

Covid-19 Vaccines Development

SARS Vaccines Development

MERS Vaccines Development

A selection of companies mentioned include:

For more information about this report visit https://www.researchandmarkets.com/r/33tnpz

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Go here to see the original:

Global COVID-19 Vaccines Pipeline 2020: 150 Organizations' Vaccines for COVID-19, SARS and MERS - PRNewswire